Marlene Leuenberger, VP and General Manager of Quotient Sciences Philadelphia, featured in CPHI Online's 'A Day in the Life of a Vice President and General Manager'.
When asked about her role at Quotient Sciences, Marlene shared that she joined Quotient Sciences in 2024 as Vice President and General Manager, overseeing two facilities located near Philadelphia, PA. Both sites specialize in small-molecule oral solid dose formulation development and drug product manufacturing. She explained how she leads Quotient Sciences' teams in delivering high-quality services in drug product formulation and manufacturing.
When asked what she enjoys most about her role, Marlene spoke on the momentum that Quotient Sciences' Translational Pharmaceutics® programs are gaining, explaining how this allows customers to achieve results more efficiently. Marlene stated, "After we develop and manufacture oral drug products in Philadelphia and Miami conducts on-site dosing, we can quickly help our customers act on clinical data. If the Miami team needs a formulation or dose adjustment, our Philly sites can respond immediately." She emphasized the benefit of not having delays in the process as there can be when working between CRO and CDMO providers.
When discussing the next big opportunity in this sector of the pharma industry, Marlene spoke on the current excitement of figuring out how to leverage AI and how to respond the upcoming regulatory changes taking effect.
Read Marlene's full feature on the CPHI Online site here.